Alovudine
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | Fluorothymidine |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H13FN2O4 |
| Molar mass | 244.222 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Alovudine (fluorothymidine) is an antiviral agent which was being developed by Medivir. It was discontinued after a Phase II trial in 2005 due to toxicity. It is a DNA polymerase inhibitor.
See also
- Fluorothymidine F-18, an isotopically enriched version of alovudine used as a PET tracer
| Baltimore I |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B (VII) | |||||||||||||||||||||
| Multiple/general |
|
||||||||||||||||||||
| |||||||||||||||||||||
| Hepatitis C |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Hepatitis D | |||||||||
| Picornavirus | |||||||||
| Anti-influenza agents | |||||||||
| Multiple/general |
|
||||||||
| |||||||||